Quality of life in 1000 patients with early relapsing–remitting multiple sclerosis

Abstract

Quality of life is considerably impaired in early stages of MS. Treatment initiation with IM IFNbeta attenuates MS disease activity and improves QoL. Inability to work early during the disease is a major challenge for the social security systems.